ADRA1D receptor antagonist 1 HCl

Research use only, not for human use.

ADRA1D receptor antagonist 1 HCl is an orally active, potent and selective α1D adrenergic receptor antagonist (Ki: 1.6 nM) with potential antiproliferative activity.

ADRA1D receptor antagonist 1 is a potent, selective and orally active α1D adrenoceptor antagonist, with a Ki of 1.6 nM.

ADRA1D receptor antagonist 1 shows low hERG inhibition.ADRA1D receptor antagonist 1 exhibits higher selectivity for α1D-AR over α1A- and α1B-ARs .

ADRA1D receptor antagonist 1 (4.4 μg/kg; i.v.) dose-dependently decreases the non-voiding bladder contractions during the urinary storage phase in rats with BOO.Animal Model:Rat with bladder outlet obstruction (BOO)Dosage:4.4 μg/kgAdministration: Intravenous injectionResult:Dose-dependently decreased the non-voiding bladder contractions during urinary storage phase in rats with BOO.

——

GPCR/G Protein

Adrenergic Receptor

Adrenergic Receptor

——

——

1191908-14-1

337.2

C15H14Cl2N4O

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (296.56 mM; Ultrasonic )

Cl.C[C@H](c1cccc(c1)C#N)n1cc(Cl)cc(C(N)=O)c1=N

——

(-20℃)

With Ice Pack

≥ 2 years